-
EP4129290
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP4129290
| Cited in | Search | Type: | Patent literature | Publication No.: | US2007142459
[XYA] (SCHLEGEL RICHARD et al.) [X] 1,4,6,8,12,14 * claims 1-12, 46-47 *[Y] 1-14 [A] 15 | Type: | Patent literature | Publication No.: | US2014011829
[XYA] (STEELE ROBERT LEWIS et al.) [X] 1,4-5,8,11-13 * page 105; examples 1-6 *[Y] 1-14 [A] 15 | Type: | Patent literature | Publication No.: | CN101857613
[XYA] (XINJIANG TECH INST PHYSICS CAS et al.) [X] 1,4,6,8,12,14 * example 1; claims 1-5 *[Y] 1-14 [A] 15 | Type: | Patent literature | Publication No.: | CN101898966
[XYA] (XINJIANG TECH INST PHYSICS CAS et al.) [X] 1,4,6,8,12,14 * example 1 *[Y] 1-14 [A] 15 | Type: | Non-patent literature | Publication information: | [XYA] WAXMAN MATTHEW ET AL: "Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study", THE LANCET INFECTIOUS DISEASES, ELSEVIER, AMSTERDAM, NL, vol. 17, no. 6, 1 March 2017 (2017-03-01), pages 654 - 660, XP085037404, ISSN: 1473-3099, DOI: 10.1016/S1473-3099(17)30112-3 [X] 1,4,6,8,12,14 * the whole document * [Y] 1-14 [A] 15 | DOI: | http://dx.doi.org/10.1016/S1473-3099(17)30112-3 | Type: | Non-patent literature | Publication information: | [XYA] LANE THOMAS R. ET AL: "Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection", PLOS NEGLECTED TROPICAL DISEASES, vol. 13, no. 11, 21 November 2019 (2019-11-21), pages 1 - 26, XP055853399, DOI: 10.1371/journal.pntd.0007890 [X] 1-2,6-7,10,14 * pages 16-20; figures 4-6 *[Y] 1-14 [A] 15 | DOI: | http://dx.doi.org/10.1371/journal.pntd.0007890 | Type: | Non-patent literature | Publication information: | [XYA] MORI GIORGIA ET AL: "The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase", TUBERCULOSIS, ELSEVIER, GB, vol. 112, 11 August 2018 (2018-08-11), pages 98 - 109, XP085468029, ISSN: 1472-9792, DOI: 10.1016/J.TUBE.2018.08.004 [X] 1-2,6-7,14 * page 105 *[Y] 1-14 [A] 15 | DOI: | http://dx.doi.org/10.1016/j.tube.2018.08.004 | Type: | Non-patent literature | Publication information: | [XI] SHIN POONG PHARM. CO. LTD.: "PYRAMAX", 28 June 2019 (2019-06-28), pages 1 - 2, XP093066908, Retrieved from the Internet | Cited in | International search | Type: | Patent literature | Publication No.: | US2007142459
[X] (SCHLEGEL RICHARD et al.) [X] 2,9,10,14,18,25,26,30 * See paragraphs [0034]-[0036] and [0047]-[0048]. * | Type: | Patent literature | Publication No.: | KR20060039286
[A] (SHIN POONG PHARMACEUTICAL CO et al.) [A] 1-32 * See claims 1-4 and 11-13. * | Type: | Patent literature | Publication No.: | US2015196530
[A] (SCHLEGEL RICHARD et al.) [A] 1-32 * See entire document. * | Type: | Non-patent literature | Publication information: | [A] LANE THOMAS R., MASSEY CHRISTOPHER, COMER JASON E., ANANTPADMA MANU, FREUNDLICH JOEL S., DAVEY ROBERT A., MADRID PETER B., EKINS S: "Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection", PLOS NEGLECTED TROPICAL DISEASES, vol. 13, no. 11, 21 November 2019 (2019-11-21), pages 1 - 26, XP055853399, ISSN: 1935-2735, DOI: 10.1371/journal.pntd.0007890 [A] 2,3,6-13,15,16,18,19,22-29,31,32 | DOI: | http://dx.doi.org/10.1371/journal.pntd.0007890 | Type: | Non-patent literature | Publication information: | [A] PRYCE JOSEPH, HINE PAUL: "Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria", COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 8 January 2019 (2019-01-08), pages 1 - 98, XP055853401, DOI: 10.1002/14651858.CD006404.pub3 [A] 1-32 * See abstract and inner pages 2-95. * | DOI: | http://dx.doi.org/10.1002/14651858.CD006404.pub3 | Type: | Non-patent literature | Publication information: | [A] PETERS W., ROBINSON B. L.: "The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin", ANNALS OF TROPICAL MEDICINE & PARASITOLOGY, vol. 91, no. 2, 1 March 1997 (1997-03-01), pages 141 - 145, XP009530984, ISSN: 0003-4983, DOI: 10.1080/00034983.1997.11813123 [A] 1-32 * See abstract and pages 141-145. * | DOI: | http://dx.doi.org/10.1080/00034983.1997.11813123 | Type: | Non-patent literature | Publication information: | [PX] JOON-YONG BAE, GEE EUN LEE, HEEDO PARK, JUYOUNG CHO, YUNG-EUI KIM, JOO-YEON LEE, CHUNG JU, WON-KI KIM, JIN IL KIM, MAN-SEONG PARK: "Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza", BIORXIV, 28 July 2020 (2020-07-28), pages 1 - 10, XP055853402, DOI: 10.1101/2020.07.28.225102 [PX] 1-10,14-26,30-32 * See abstract, inner pages 6-10 and Fig. 1. * | DOI: | http://dx.doi.org/10.1101/2020.07.28.225102 | Type: | Non-patent literature | Publication information: | [PX] KRISHNA SANJEEV; AUGUSTIN YOLANDA; WANG JIGANG; XU CHENGCHAO; STAINES HENRY M.; PLATTEEUW HANS; KAMARULZAMAN ADEEBA; SALL AMADOU; : "Repurposing Antimalarials to Tackle the COVID-19 Pandemic", TRENDS IN PARASITOLOGY, vol. 37, no. 1, 19 October 2020 (2020-10-19), GB, pages 8 - 11, XP086412305, ISSN: 1471-4922, DOI: 10.1016/j.pt.2020.10.003 [PX] 1-10,14-26,30-32 * See abstract, pages 8-11 and Fig. 1. * | DOI: | http://dx.doi.org/10.1016/j.pt.2020.10.003 | Cited in | by applicant | Type: | Non-patent literature | Publication information: | "Remington's Pharmaceutical Science", 1975, MACK PUBLISHING COMPANY [A] 2,3,6-13,15,16,18,19,22-29,31,32 | Type: | Non-patent literature | Publication information: | "Remington's Pharmaceutical Sciences", 1995, MACK PUBLISHING COMPANY |